Pikounis, T., Shakhnazaryan, N., Semaan, M., Chiu, C., Pan, E., Fitzgerald, K. N., Hsu, S. C., Younger, N. S., Zhu, X., Bose, R., Desai, A., Kouchkovsky, I. D., Kwon, D. H., Flavell, R. R., Friedlander, T. W., Chou, J., Aggarwal, R. R., Small, E. J., Hope, T. A., Koshkin, V. S. (2026). Safety data from UPLIFT: Phase I/II study of CDK4/6 inhibition with abemaciclib to upregulate PSMA expression prior to
                    <sup>177</sup>
                    Lu-PSMA-617 treatment in patients with metastatic castrate resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.163